Ovid Therapeutics Inc. (OVID) Financials

OVID Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 225.6 million 27.4 million
Dec. 31, 2025 150.9 million 20.3 million
Sept. 30, 2025 63.8 million 19.2 million
June 30, 2025 77.4 million 21.6 million

OVID Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -13.9 million 1.0 million
Dec. 31, 2025 -10.4 million 1.2 million
Sept. 30, 2025 -12.9 million 1.1 million
June 30, 2025 -4.8 million 1.2 million

OVID Net Income

No data available :(

OVID Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 155.5 million - 13.1 million
Dec. 31, 2025 69.6 million - 13.4 million
Sept. 30, 2025 25.6 million - 13.8 million
June 30, 2025 38.3 million - 14.1 million

OVID Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 73.7 million
Dec. 31, 2025 81.7 million
Sept. 30, 2025 71.1 million
June 30, 2025 71.1 million

OVID Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 11.1 million 6.7 million -
Dec. 31, 2025 - 6.6 million 6.4 million -
Sept. 30, 2025 - 5.9 million 6.8 million -
June 30, 2025 - 6.5 million 4.9 million -

OVID Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 35000
Dec. 31, 2025 718000 44000
Sept. 30, 2025 132000 17000
June 30, 2025 6.3 million 99000

OVID Revenue by Segment
Graph available only for paid members. Upgrade to see it.

OVID

Price: $2.42

52 week price:
0.27
3.11

Earnings Per Share: -0.21 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 61100

Ebitda: -9.4 million

Market Capitalization: 316.5 million

Links: